Los resultados preliminares de un ensayo clínico liderado por el Instituto Hospital del Mar de Investigaciones Médicas y el Hospital del Mar muestran una buena respuesta a un fármaco en pacientes c...
Read moreThe Food and Drug Administration (FDA) announced its intention to clean the drug listing database from outdated and uncertified records. This action is not limited only to listings for finished dru...
Read moreIDIVAL researchers belonging to the group of Epidemiology and Pathogenic and Molecular Mechanisms of Infectious Diseases and Microbiology led by Dr. Carmen Fariñas, head of the Infectious Se...
Read moreEl trabajo se ha presentado en el Congreso Europeo y Mundial de Cardiología de París y se ha publicado en ‘The New England Journal of Medicine’
Read moreLa investigación, de científicos de la URV y de la Universidad de Pensilvania, ha sido portada del último número de la revista Biomacromolecules de la Sociedad Americana de Química
Read moreAdministrating methadone instead of morphine is he most indicated pharmacological treatment in the fight against chronic pain, according to a new article published in the Journal of Clinical Inv...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, today p...
Read moreA study, in which Dr. Jordi Surrallés, Professor of Genetics at the UAB, and his research group have participated, presents the first clinical demonstration of engraftment and expansion of gene-corre...
Read moreThe institution has also renewed the concession to three other initiatives previously included in its programs
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical needs, announc...
Read moreXOMA Corporation (NASDAQ: XOMA), announced today it has acquired a royalty interest in six clinical-stage assets targeting the adenosine pathway for $10.0 million from Palobiofarma S.L.One of the asse...
Read moreThis weekend on the ground at the ESMO Congress 2019, 27 September – 01 October, Barcelona, organized in partnership with the European Association for Cancer Research (EACR), several of our faculty ...
Read more